Get the Stockscreener App
3.45
3.09%
-0.11
Onconetix Inc stock is traded at $3.45, with a volume of 381.79K.
It is down -3.09% in the last 24 hours and down -26.60% over the past month.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
See More
Previous Close:
$3.56
Open:
$3.43
24h Volume:
381.79K
Relative Volume:
0.51
Market Cap:
$1.80M
Revenue:
-
Net Income/Loss:
$-53.12M
P/E Ratio:
-0.0317
EPS:
-108.8
Net Cash Flow:
$-15.86M
1W Performance:
-16.87%
1M Performance:
-26.60%
6M Performance:
-92.54%
1Y Performance:
-99.32%
1-Day Range:
$3.1605
$3.46
1-Week Range:
$3.08
$4.59
52-Week Range:
$3.08
$656.88
Onconetix Inc Stock (ONCO) Company Profile
Name
Onconetix Inc
Sector
Industry
Phone
513-620-4101
Address
201 E. FIFTH STREET, CINCINNATI
Compare ONCO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
3.45 | 1.86M | 0 | -53.12M | -15.86M | -108.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Onconetix Inc Stock (ONCO) Latest News
Price action breakdown for Onconetix Inc.Free AI Driven Stock Trend Forecast - Newser
Real time breakdown of Onconetix Inc. stock performanceTrade Setup Builder with Custom Alerts - Newser
What makes Onconetix Inc. stock price move sharplyFree High Yield Stock Screening Results - Newser
Quantitative breakdown of Onconetix Inc. recent moveFree Community Strategy With High Win Rate - Newser
What institutional investors are buying Onconetix Inc. stockAI Powered Review For 2025 - jammulinksnews.com
Using data models to predict Onconetix Inc. stock movementFree Smart Allocation Stock Pick Insights - Newser
How Onconetix Inc. stock performs during market volatilityStock Market Watch with Smart Filters - Newser
Live market analysis of Onconetix Inc.Trade Ideas Based on Fundamental Metrics - Newser
Is Onconetix Inc. forming a reversal patternFree Long Hold Safe Return Strategy - Newser
Short interest data insights for Onconetix Inc.Entry Optimization Guide with Volume Analysis - Newser
How does Onconetix Inc. generate profit in a changing economyAI Powered Entry Points From AI Tools - jammulinksnews.com
Onconetix’s Strategic Moves & Market Outlook - StocksToTrade
Onconetix Shares Skyrocket: What’s Next? - timothysykes.com
Why Onconetix Inc. stock attracts strong analyst attentionFree Watchlist for Low Risk High Return - Newser
Reversal Confirmed Onconetix Inc. Stock Rallies Above MASmart Investment Tips Gaining Popularity Among Analysts - metal.it
Can Onconetix Inc. rally from current levelsStock Market Watch with Smart Filters - Newser
How did Onconetix's revenue and expenses trend in Q3 2024? - AInvest
Can Onconetix Inc. stock recover from recent declineRisk Aware Swing Trade Analysis Insights - Newser
Why is Onconetix Inc. stock attracting strong analyst attentionBeginner Investor Insights That Work - jammulinksnews.com
Company’s Banking Shares: Up -99.37% from 52-Week Low, But Can the Momentum Hold? - investchronicle.com
What are the latest earnings results for Onconetix Inc.Record-breaking gains - jammulinksnews.com
What is the risk reward ratio of investing in Onconetix Inc. stockRemarkable growth - jammulinksnews.com
When is Onconetix Inc. stock expected to show significant growthMaximize your portfolio’s growth with expert tips - jammulinksnews.com
How volatile is Onconetix Inc. stock compared to the marketTrack top-performing stocks in real-time - jammulinksnews.com
Is Onconetix Inc. stock overvalued or undervaluedAchieve consistent profits with expert advice - jammulinksnews.com
What is Onconetix Inc. company’s growth strategyHigh-profit trading signals - jammulinksnews.com
Is it the right time to buy Onconetix Inc. stockFree Stock Market Knowledge Sharing - jammulinksnews.com
Is Onconetix Inc. a growth stock or a value stockInvest confidently with data-backed picks - jammulinksnews.com
How many analysts rate Onconetix Inc. as a “Buy”Exceptional stock performance - jammulinksnews.com
How does Onconetix Inc. compare to its industry peersMaximize portfolio value with smart investment plans - jammulinksnews.com
Buy Signal for Onconetix Inc. Stock Key Technical Indicators to WatchShort Term Risk Controlled Alerts - Newser
Onconetix Inc Stock (ONCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):